Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a primary contributor to liver‐related morbidity and mortality. Asprosin has been reported to be implicated in NAFLD. AIMS: This work is to illuminate the effects of Asprosin on NAFLD and the possible downstream mechanism. MATERIALS & METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Lu, Jinger, Jiang, Yuhua, Feng, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436697/
https://www.ncbi.nlm.nih.gov/pubmed/37647445
http://dx.doi.org/10.1002/iid3.947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436697/
https://www.ncbi.nlm.nih.gov/pubmed/37647445
http://dx.doi.org/10.1002/iid3.947

Ejemplares similares